What the studies show
Twelve-week facial studies in the late 1990s and early 2000s reported improved skin laxity, clarity and fine lines versus vehicle or comparators. Small, short, largely industry-run.
A few small or poorly-controlled human studies. Enough to be interesting; not enough to count on. Most of what gets called “clinically proven” online lives here.
- 1Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data.Int J Mol Sci, 2018;19:1987 (review)Review by the peptide's discoverer; declared interest.
- 2Leyden JJ, et al. Skin care benefits of copper peptide containing facial cream.American Academy of Dermatology meeting, 2002 (abstract)Twelve-week facial study; conference abstract, industry-supported.
In context
GHK-Cu is a naturally occurring three-amino-acid peptide that binds copper, found in plasma, saliva and urine, with levels that fall with age. Applied to skin in creams it has modest evidence from small trials for improving fine lines and skin firmness, which is why it is a common cosmetic ingredient. Injected use — increasingly promoted online — has no human evidence of any kind.
GHK-Cu is cosmetic ingredient. Legal status differs by country — see the regulation section or the jurisdiction pages.
Questions
Is GHK-Cu proven to help with skin appearance?
What studies are behind the grade?
Is GHK-Cu approved for this?
Other outcomes for GHK-Cu
- CWound healing (topical)Small trials, mixed
- DHair growthNone controlled
- DAny outcome (injected)None
Reviewed 2 September 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →